![Cureus | A Case of Severe Metabolic Acidosis due to Jardiance-Induced Euglycemic Diabetic Ketoacidosis Cureus | A Case of Severe Metabolic Acidosis due to Jardiance-Induced Euglycemic Diabetic Ketoacidosis](https://assets.cureus.com/uploads/figure/file/203396/lightbox_06b9ce30930211eb9b011de749d95624-EEu6kJXXUAM2kDa.png)
Cureus | A Case of Severe Metabolic Acidosis due to Jardiance-Induced Euglycemic Diabetic Ketoacidosis
![Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trial | Nature Medicine Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trial | Nature Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-022-01805-3/MediaObjects/41591_2022_1805_Fig1_HTML.png)
Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trial | Nature Medicine
![EASD: AstraZeneca's Farxiga cuts blood sugar, weight and insulin use in Type 1 diabetes study | Fierce Pharma EASD: AstraZeneca's Farxiga cuts blood sugar, weight and insulin use in Type 1 diabetes study | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/FiercePharma-1505380578/Farxiga.jpg/Farxiga.jpg?VersionId=YGHZeKKtBkpU9PCGQLQdYHqkUDhFdDKW)
EASD: AstraZeneca's Farxiga cuts blood sugar, weight and insulin use in Type 1 diabetes study | Fierce Pharma
![AstraZeneca's diabetes drug Farxiga nabs coveted kidney disease nod, way ahead of rival Jardiance | Fierce Pharma AstraZeneca's diabetes drug Farxiga nabs coveted kidney disease nod, way ahead of rival Jardiance | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1619989374/Farxiga%2010mg.jpg?VersionId=dHWdb1WN.E.nqpjVWVnOqyBuZk7JIEKD)
AstraZeneca's diabetes drug Farxiga nabs coveted kidney disease nod, way ahead of rival Jardiance | Fierce Pharma
![Empagliflozin (Jardiance): A Novel SGLT2 Inhibitor for the Treatment of Type-2 Diabetes. | Semantic Scholar Empagliflozin (Jardiance): A Novel SGLT2 Inhibitor for the Treatment of Type-2 Diabetes. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/46c1149c3fc6dbdb2b5d1e2499fa9a746f34db78/4-Table1-1.png)